ES353537A1 - Un procedimiento de preparacion de esteres polinicotinicos de flavonoides. - Google Patents
Un procedimiento de preparacion de esteres polinicotinicos de flavonoides.Info
- Publication number
- ES353537A1 ES353537A1 ES353537A ES353537A ES353537A1 ES 353537 A1 ES353537 A1 ES 353537A1 ES 353537 A ES353537 A ES 353537A ES 353537 A ES353537 A ES 353537A ES 353537 A1 ES353537 A1 ES 353537A1
- Authority
- ES
- Spain
- Prior art keywords
- pyridine
- polynicotinic
- esters
- hesperidin
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000002148 esters Chemical class 0.000 title abstract 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 title 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 title 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 title 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 title 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 title 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 title 1
- 229940025878 hesperidin Drugs 0.000 title 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 title 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 229930003935 flavonoid Natural products 0.000 abstract 2
- 150000002215 flavonoids Chemical class 0.000 abstract 2
- 235000017173 flavonoids Nutrition 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- MSYBLBLAMDYKKZ-UHFFFAOYSA-N hydron;pyridine-3-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=CN=C1 MSYBLBLAMDYKKZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 nicotinoyl groups Chemical group 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000024883 vasodilation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB21078/67A GB1179019A (en) | 1967-05-23 | 1967-05-23 | Polynicotinic Esters of Flavonoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES353537A1 true ES353537A1 (es) | 1969-10-01 |
Family
ID=10156835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES353537A Expired ES353537A1 (es) | 1967-05-23 | 1968-05-04 | Un procedimiento de preparacion de esteres polinicotinicos de flavonoides. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3751570A (OSRAM) |
| BE (1) | BE714423A (OSRAM) |
| CH (1) | CH478143A (OSRAM) |
| ES (1) | ES353537A1 (OSRAM) |
| FR (2) | FR1561764A (OSRAM) |
| GB (1) | GB1179019A (OSRAM) |
| NL (1) | NL132132C (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH602778A5 (OSRAM) * | 1975-05-16 | 1978-07-31 | Hommel Ag | |
| GB1575004A (en) * | 1976-03-23 | 1980-09-17 | Iverni Della Beffa Spa | Pharmacologically active polyphenolic substances |
| IT1232343B (it) * | 1989-09-28 | 1992-01-28 | Eurogefi S P A | Derivati idrosolubili di bioflavonoidi di glicosidici, procedimenti per la loro preparazione e relative composizioni farmaceutiche. |
| WO1998011876A1 (de) * | 1996-09-18 | 1998-03-26 | Marigen S.A. | Bioflavonol-glykosid-perester und ihre aufarbeitung zu pharmakologisch wirksamen konzentraten und ultramikroemulsionen |
| KR100213895B1 (ko) * | 1996-10-14 | 1999-08-02 | 박원훈 | 감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물 |
| AUPR255401A0 (en) * | 2001-01-16 | 2001-02-08 | Novogen Research Pty Ltd | Regulation of lipids and/or bone density and compositions therefor |
| US8093273B2 (en) | 2004-10-20 | 2012-01-10 | Resverlogix Corp. | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| EP1909788A2 (en) | 2005-07-29 | 2008-04-16 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| EP2118074B1 (en) | 2007-02-01 | 2014-01-22 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
| US8114995B2 (en) | 2008-06-26 | 2012-02-14 | Resverlogix Corp. | Methods of preparing quinazolinone derivatives |
| ES2542835T3 (es) | 2009-01-08 | 2015-08-12 | Resverlogix Corporation | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
| US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
| HRP20182200T1 (hr) | 2009-04-22 | 2019-03-22 | Resverlogix Corp. | Nova protuupalna sredstva |
| TR201909777T4 (tr) | 2011-11-01 | 2019-07-22 | Resverlogix Corp | Sübsti̇tüe ki̇nazoli̇nonlara yöneli̇k oral çabuk salimli formülasyonlar |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| AU2013365926B9 (en) | 2012-12-21 | 2019-01-17 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
| WO2016147053A1 (en) | 2015-03-13 | 2016-09-22 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
-
1967
- 1967-05-23 GB GB21078/67A patent/GB1179019A/en not_active Expired
-
1968
- 1968-04-29 BE BE714423D patent/BE714423A/xx not_active IP Right Cessation
- 1968-04-30 CH CH644668A patent/CH478143A/fr not_active IP Right Cessation
- 1968-04-30 FR FR1561764D patent/FR1561764A/fr not_active Expired
- 1968-05-03 NL NL6806337A patent/NL132132C/xx active
- 1968-05-04 ES ES353537A patent/ES353537A1/es not_active Expired
- 1968-07-24 FR FR160341A patent/FR7941M/fr not_active Expired
-
1970
- 1970-07-16 US US00055620A patent/US3751570A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3751570A (en) | 1973-08-07 |
| GB1179019A (en) | 1970-01-28 |
| FR7941M (OSRAM) | 1970-05-25 |
| NL132132C (OSRAM) | 1971-03-15 |
| DE1770324B2 (de) | 1976-07-22 |
| FR1561764A (OSRAM) | 1969-03-28 |
| CH478143A (fr) | 1969-09-15 |
| BE714423A (OSRAM) | 1968-09-16 |
| NL6806337A (OSRAM) | 1968-11-06 |
| DE1770324A1 (de) | 1972-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES353537A1 (es) | Un procedimiento de preparacion de esteres polinicotinicos de flavonoides. | |
| IL35400A0 (en) | Furoyl and thenoylphenoxy acetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL35668A0 (en) | Xanthone derivatives,their preparation and pharmaceutical compositions containing them | |
| BE586626A (fr) | Nouveaux dérivés du pyrazole, leur préparation et compositions pharmaceutiques en contenant. | |
| GB1223461A (en) | Pteridine derivatives | |
| JPS52108028A (en) | Remedies for dysacousis | |
| IL38090A0 (en) | Pharmaceutical compositions containing nicotinic acid derivatives | |
| ES337963A1 (es) | Procedimiento para la produccion de derivados de nitrofura-no con efecto antibiotico. | |
| ES415226A1 (es) | Procedimiento para la obtencion de ascorbato de vincamina. | |
| GB1270049A (en) | New pharmaceutical product | |
| GB1409149A (en) | Quecetin derivatives and pharmaceutical uses thereof | |
| GB1178012A (en) | A Method for the Production of Pyridine Derivatives | |
| GB1141214A (en) | New derivatives of proscillaridin a | |
| SE400972B (sv) | Omettade fosforhaltiga karbonsyraderivat till anvendning for framstellning av homo- och sampolymerisat med akrylsyraderivat, styren och vinylforeningar | |
| JPS525769A (en) | Preparation of 3-substituted pyrolidine derivatives | |
| GB1090279A (en) | Glucosides and galactosides | |
| GB1321692A (en) | Dihydro-3-piperidyl-2 3h-furanone derivatives | |
| FI52092C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-alkyyli-6-fenyyli-2,4-dihydr o-1H-s-triatsolo(4,3-a)(1,4)bentsodiatsepiini-1-oni-5N-oksidi-johdanna isten valmistamiseksi. | |
| GB1332635A (en) | Rutin complexes | |
| JPS5432493A (en) | Preparation of macrolide antibiotics derivatives | |
| GB1027891A (en) | Esters of dianhydro-hexitols | |
| GB1169074A (en) | Improvements in or relating to Hepato-Protective Drugs | |
| JPS5251362A (en) | Preparation of optically active pyrrolidine derivatives | |
| GB920141A (en) | Therapeutic chromone derivative, its production and compositions containing the same | |
| JPS5240282A (en) | Treatment device for a high speed ddc |